Bulgaria Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Bulgaria Pharmaceuticals and Healthcare Report Q3 2013 Jul 17th 2013, 00:00, by rnrmahesh Executive Summary BMI View: According to industry sources, the Bulgarian pharmaceuticals market has reached a standstill. This is expected to continue throughout 2013, due to the decline in drug prices and the stagnant health insurance fund budget. We expect that the market will post single-digit value increase, on account of inflationary pressures and continued volume demand. Political uncertainty will also add to the negative pressures affecting the wider healthcare market. Headline Expenditure Projections ? Pharmaceuticals: BGN2.22bn (US$1.46bn) in 2012 to BGN2.31bn (US$1.58bn) in 2013; +3.8% in local currency terms and +8.0% in US dollar terms. Local currency forecast broadly in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=107749. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/bulgaria-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions